Search 25,000+ prices/

Pantoprazole Price by Country (2026)

Compiled by the TrustClinix data team · Medical review pending7 official sourcesPrices last checked 25 October 2026How we get our data

$0.013 – $0.34 per unit

Official 2026 prices for pantoprazole 40 mg gastro-resistant tablet in India, the United States, the United Kingdom, Australia, South Africa and the UAE, converted to US dollars.

Pantoprazole reduces the amount of acid the stomach makes and is used for acid reflux and stomach ulcers.

Pantoprazole 40 mg gastro-resistant tablet: price by country

Price by country
CountryPrice typeLocal price per unitPer unit (USD)30 units (USD)
IndiaJan Aushadhi retail price (MRP)₹1.25$0.013$0.39
United StatesPharmacy acquisition cost (NADAC)$0.037$0.037$1.10
United KingdomNHS Drug Tariff reimbursement price£0.033$0.043$1.30
AustraliaPBS approved ex-manufacturer priceA$0.096$0.067$2.02
South AfricaSingle Exit Price (SEP)R4.34$0.26$7.84
United Arab EmiratesAbu Dhabi DoH public priceAED 1.23$0.34$10.06
India$0.013
United States$0.037
United Kingdom$0.043
Australia$0.067
South Africa$0.26
United Arab Emirates$0.34
Pantoprazole 40 mg gastro-resistant tablet: price per unit by country (USD)

Each country publishes a different type of price, explained on each country page. Converted at ECB reference rates of 23 October 2026.

More countries

Pantoprazole prices in South Africa, the UAE, Saudi Arabia, Australia, the United Kingdom and the United States

About pantoprazole

Pantoprazole is a proton pump inhibitor taken once a day before a meal. It is used for acid reflux, to heal and prevent stomach ulcers, and to protect the stomach in people taking certain other medicines. The tablets are gastro-resistant, meaning they must be swallowed whole so the medicine is released in the intestine.

Drug class: Proton pump inhibitor. Used for: acid reflux (GERD).

Quick answers

Frequently asked questions

How much does pantoprazole cost?
Pantoprazole 40 mg gastro-resistant tablet costs between $0.013 and $0.34 per unit in the countries we cover, based on official price lists.
Evidence

Sources

  1. Pharmaceuticals & Medical Devices Bureau of India (PMBI), Department of Pharmaceuticals, Government of India. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) Product & MRP List. janaushadhi.gov.in/product-portfolio/product-mrp-list. Retrieved 25 October 2026.
  2. Centers for Medicare & Medicaid Services (CMS). NADAC (National Average Drug Acquisition Cost) 2026 (as of 2026-10-21). data.medicaid.gov/dataset/fbb83258-11c7-47f5-8b18-5f8e79f7e704. Retrieved 25 October 2026.
  3. NHS Business Services Authority (NHSBSA). Drug Tariff Part VIIIA Category M prices - October 2026. www.nhsbsa.nhs.uk/sites/default/files/2026-09/Cat%20M%20Prices%20-%20Q. Retrieved 25 October 2026.
  4. Australian Government Department of Health, Disability and Ageing. Pharmaceutical Benefits Scheme (PBS) Schedule, 1 October 2026 (PBS API). www.pbs.gov.au/. Retrieved 25 October 2026.
  5. National Department of Health, South Africa. Database of Medicine Prices (Single Exit Price), effective 1 October 2026. www.health.gov.za/nhi-pee/. Retrieved 25 October 2026.
  6. Department of Health – Abu Dhabi. Drug Master price list (public prices), version effective 2 October 2026. www.doh.gov.ae/en/resources/drug-prices. Retrieved 25 October 2026.
  7. European Central Bank. Euro foreign exchange reference rates (2026-10-23). www.ecb.europa.eu/stats/eurofxref/eurofxref-daily.xml. Retrieved 25 October 2026.

Important: These are published reference prices and estimates, not a quote, and not medical advice. Actual costs depend on the hospital, your health, the exact treatment and your insurance. Always confirm the price with the provider before treatment. Read our disclaimer · Report an error

Related medicines